Topical pyruvic acid (70%) versus topical salicylic acid (16.7%) compound in treatment of plantar warts: A randomized controlled trial

Authors
Zabihollah Shahmoradi 1
Fatima Assaf 1
Hassan Al Said 2
Parastoo Khosravani 1
Sayyed Mohsen Hosseini 1
1 Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Biochemistry, Faculty of Sciences, EDST-PRASE, Lebanese University, Hadath-Beirut, Lebanon
Abstract
Background: Recurrence rate is considerable with current topical treatments of plantar warts. We compared the efficacy of topical pyruvic acid (70%) with salicylic acid (16.7%) compound in treating multiple plantar warts.
Materials and Methods: In this randomized controlled trial, 60 patients with multiple plantar warts were equally randomized to receive either pyruvic acid 70% or compound salicylic acid solution (salicylic acid 16.7%, lactic acid 16.7%, and collodion 100%) that was topically applied twice a day for 4 weeks. Patients were visited every 2 weeks for 1 month after starting treatment and then every 1 month for another 2 months. The number and size of warts, treatment complications (pain, burning, scar, pigmentation, and crust), and recurrence were evaluated.
Results: Warts' number was decreased by -13.12 ± 25.6% with pyruvic acid and by -23.0 ± 28.0% with compound salicylic acid (P = 0.159) after treatment. Warts' size was decreased by -43.47 ± 57.0% with pyruvic acid and by -37.40 ± 32.76% with compound salicylic acid (P = 0.615) after treatment. There was no difference between the two groups in cumulative incidence of treatment complications (P > 0.05). Also, there was no difference between the two groups in recurrence rate at 2 months (10 vs. 16.7%, P = 0.500) or at 3 months after treatment (3.3 vs. 6.7%, P = 0.335).
Conclusion: Topical pyruvic acid and compound salicylic acid had the same efficacy and complications in treating plantar warts. Decision for choosing the treatment can be made based on the costs and individual factors as well as patients preferences.

Keywords

1.
Kilkenny M, Merlin K, Young R, Marks R. The prevalence of common skin conditions in Australian school students: 1. Common, plane and plantar viral warts. Br J Dermatol 1998;138:840-5.  Back to cited text no. 1
    
2.
Bacelieri R, Johnson SM. Cutaneous warts: An evidence-based approach to therapy. Am Fam Physician 2005;72:647-52.  Back to cited text no. 2
    
3.
Kwok CS, Holland R, Gibbs S. Efficacy of topical treatments for cutaneous warts: A meta-analysis and pooled analysis of randomized controlled trials. Br J Dermatol 2011;165:233-46.  Back to cited text no. 3
    
4.
Viennet C, Gheit T, Muret P, Aubin F, Cabou J, Marchal A, et al. Assessment of the efficacy of a new formulation for plantar wart mummification: New experimental design and human papillomavirus identification. Clin Exp Dermatol 2013;38:85-8.  Back to cited text no. 4
    
5.
Brentjens MH, Yeung-Yue KA, Lee PC, Tyring SK. Human papillomavirus: A review. Dermatol Clin 2002;20:315-31.  Back to cited text no. 5
    
6.
Kwok CS, Gibbs S, Bennett C, Holland R, Abbott R. Topical treatments for cutaneous warts. Cochrane Database Syst Rev 2012;9:CD001781.  Back to cited text no. 6
    
7.
Tosson Z, Attwa E, Al-Mokadem S. Pyruvic acid as a new therapeutic peeling agent in acne, melasma and warts. Egypt Dermatol Online J 2006;2:7.  Back to cited text no. 7
    
8.
Caperton C, Valencia O, Romanelli P, Fulton J. Pyruvic acid facilitates the removal of actinic keratoses and seborrheickeratoses. Dermatol Surg 2012;38:1710-5.  Back to cited text no. 8
    
9.
Van Scott EJ, Yu RJ. Hyperkeratinization, corneocyte cohesion, and alpha hydroxy acids. J Am Acad Dermatol 1984;11:867-79.  Back to cited text no. 9
    
10.
Halasz CL. Treatment of warts with topical pyruvic acid: With and without added 5-fluorouracil. Cutis 1998;62:283-5.  Back to cited text no. 10
    
11.
Fulton JE, Porumb S. Chemical peels: Their place within the range of resurfacing techniques. Am J Clin Dermatol 2004;5:179-87.  Back to cited text no. 11
    
12.
Khattar JA, Musharrafieh UM, Tamim H, Hamadeh GN. Topical zinc oxide vs. salicylic acid-lactic acid combination in the treatment of warts. Int J Dermatol 2007;46:427-30.  Back to cited text no. 12
    
13.
Coskey RJ. Treatment of plantar warts in children with a salicylic acid-podophyllin-cantharidin product. Pediatr Dermatol 1984;2:71-3.  Back to cited text no. 13
    
14.
Hursthouse MW. A controlled trial on the use of topical 5-fluorouracil on viral warts. Br J Dermatol 1975;92:93-6.  Back to cited text no. 14
    
15.
Ebrahimi S, Dabiri N, Jamshidnejad E, Sarkari B. Efficacy of 10% silver nitrate solution in the treatment of common warts: A placebo-controlled, randomized, clinical trial. Int J Dermatol 2007;46:215-7.  Back to cited text no. 15
    
16.
Bruggink SC, Gussekloo J, Berger MY, Zaaijer K, Assendelft WJ, de Waal MW, et al. Cryotherapy with liquid nitrogen versus topical salicylic acid application for cutaneous warts in primary care: Randomized controlled trial. CMAJ 2010;182:1624-30.  Back to cited text no. 16
    
17.
Cockayne S, Hewitt C, Hicks K, Jayakody S, Kang'ombe AR, Stamuli E, et al. Cryotherapy versus salicylic acid for the treatment of plantar warts (verrucae): A randomised controlled trial. BMJ 2011;342:d3271.  Back to cited text no. 17
Advanced Biomedical Research
Volume 2015, May
May 2015
Pages 1-5